Unlocking The Potential of RPL3L: A Protein Involved in Gene Regulation and Drug Targeting

Target Name: RPL3L

NCBI ID: G6123

RPL3L

Unlocking The Potential of RPL3L: A Protein Involved in Gene Regulation and Drug Targeting

Ribosomal subunit protein (RSP) L3-like, or RPL3L, is a protein that is expressed in various cell types of the human body. It is a key component of the ribosome, which is the protein machine that synthesizes proteins in the cell. RPL3L is a large protein, with a molecular weight of approximately 180 kDa.

One of the unique features of RPL3L is its structure. It has a unique fusiform shape, with a long, slender neck and a large, bulbous body. This shape allows it to interact with other proteins in the cell, including the factors that regulate the ribosome.

RPL3L is also known for its role in the regulation of gene expression. It has been shown to play a role in the regulation of gene expression by binding to specific DNA sequences. This interaction between RPL3L and DNA has important implications for the study of gene regulation and the development of new treatments for various diseases.

In addition to its role in gene regulation, RPL3L is also a potential drug target. Its unique shape and the fact that it is expressed in various cell types make it an attractive target for small molecules that can modulate its function. This has led to a growing interest in the development of compounds that can interact with RPL3L and improve its function as a drug.

One of the most promising compounds that has been shown to interact with RPL3L is called NEDD8, which is a non-coding RNA molecule that has been shown to interact with RPL3L. NEDD8 has been shown to play a role in the regulation of gene expression and has been shown to interact with RPL3L in a similar way to small molecules that have been shown to interact with RPL3L.

In addition to its potential as a drug target, RPL3L is also a potential biomarker. Its unique shape and the fact that it is expressed in various cell types make it an attractive target for imaging technologies. This has led to a growing interest in the development of new imaging techniques that can detect RPL3L in cells and use it as a biomarker for various diseases.

In conclusion, RPL3L is a large and unique protein that is expressed in various cell types of the human body. Its unique shape and the fact that it is involved in the regulation of gene expression make it an attractive target for small molecules that can modulate its function. In addition, its potential as a drug target and biomarker make it an interesting target for further research. Further studies are needed to fully understand the role of RPL3L in the cell and its potential as a new drug or biomarker.

Protein Name: Ribosomal Protein L3 Like

Functions: Heart- and skeletal muscle-specific component of the ribosome, which regulates muscle function. Component of the large ribosomal subunit in striated muscle cells: replaces the RPL3 paralog in the ribosome in these cells. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. Inhibits myotube growth and muscle function

The "RPL3L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL3L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets